医学
经皮冠状动脉介入治疗
心肌梗塞
内科学
急性肾损伤
心脏病学
肌酐
优势比
ST段
人口
环境卫生
作者
Yalçın Velibey,Ahmet Öz,Ozan Tanık,Tolga Sinan Güvenç,Koray Kalenderoğlu,Ayça Gümüşdağ,Evliya Akdeniz,Mehmet Bozbay,Ahmet İlker Tekkeşin,Özge Güzelburç,Mert İlker Hayıroğlu,Ahmet Taha Alper,Murat Uğur,Mehmet Eren
出处
期刊:Angiology
[SAGE Publishing]
日期:2016-07-29
卷期号:68 (5): 419-427
被引量:46
标识
DOI:10.1177/0003319716660244
摘要
We aimed to investigate the relationship between platelet-to-lymphocyte ratio (PLR) and contrast-induced acute kidney injury (CI-AKI) in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI). A total of 2563 patients diagnosed with STEMI and underwent primary pPCI were retrospectively included in the study. Levels of PLR and creatinine were measured before and at 72 hours after pPCI. Patients were divided into 2 groups: non-CI-AKI group and CI-AKI group. Contrast-induced acute kidney injury occurred in 6.4% of the overall study population. Patients in the CI-AKI group had significantly higher PLR than those in the non-CI-AKI group (169.18 ± 81.01 vs 149.49 ± 74.54, P < .001). In logistic regression analysis, PLR was an independent predictor of CI-AKI (odds ratio [OR]: 1.774, 95% CI: 1.243-2.532, P = .002), along with age, use of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker prior to the procedure, preprocedural creatinine level, amount of contrast material used during the procedure, and hypertension. Increased PLR levels are independently associated with a greater risk of CI-AKI in patients undergoing primary PCI for STEMI.
科研通智能强力驱动
Strongly Powered by AbleSci AI